Literature DB >> 34218880

Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis.

Martha Grogan1, Francisco Lopez-Jimenez2, Michal Cohen-Shelly2, Angela Dispenzieri3, Zachi I Attia2, Omar F Abou Ezzedine2, Grace Lin2, Suraj Kapa2, Daniel D Borgeson2, Paul A Friedman2, Dennis H Murphree4.   

Abstract

OBJECTIVE: To develop an artificial intelligence (AI)-based tool to detect cardiac amyloidosis (CA) from a standard 12-lead electrocardiogram (ECG).
METHODS: We collected 12-lead ECG data from 2541 patients with light chain or transthyretin CA seen at Mayo Clinic between 2000 and 2019. Cases were nearest neighbor matched for age and sex, with 2454 controls. A subset of 2997 (60%) cases and controls were used to train a deep neural network to predict the presence of CA with an internal validation set (n=999; 20%) and a randomly selected holdout testing set (n=999; 20%). We performed experiments using single-lead and 6-lead ECG subsets.
RESULTS: The area under the receiver operating characteristic curve (AUC) was 0.91 (CI, 0.90 to 0.93), with a positive predictive value for detecting either type of CA of 0.86. By use of a cutoff probability of 0.485 determined by the Youden index, 426 (84%) of the holdout patients with CA were detected by the model. Of the patients with CA and prediagnosis electrocardiographic studies, the AI model successfully predicted the presence of CA more than 6 months before the clinical diagnosis in 59%. The best single-lead model was V5 with an AUC of 0.86 and a precision of 0.78, with other single leads performing similarly. The 6-lead (bipolar leads) model had an AUC of 0.90 and a precision of 0.85.
CONCLUSION: An AI-driven ECG model effectively detects CA and may promote early diagnosis of this life-threatening disease.
Copyright © 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34218880     DOI: 10.1016/j.mayocp.2021.04.023

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

Review 1.  Artificial Intelligence in Cardiovascular Medicine: Current Insights and Future Prospects.

Authors:  Ikram U Haq; Karanjot Chhatwal; Krishna Sanaka; Bo Xu
Journal:  Vasc Health Risk Manag       Date:  2022-07-12

Review 2.  Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools.

Authors:  Demilade A Adedinsewo; Amy W Pollak; Sabrina D Phillips; Taryn L Smith; Anna Svatikova; Sharonne N Hayes; Sharon L Mulvagh; Colleen Norris; Veronique L Roger; Peter A Noseworthy; Xiaoxi Yao; Rickey E Carter
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 23.213

3.  Artificial intelligence and imaging: Opportunities in cardio-oncology.

Authors:  Nidhi Madan; Julliette Lucas; Nausheen Akhter; Patrick Collier; Feixiong Cheng; Avirup Guha; Lili Zhang; Abhinav Sharma; Abdulaziz Hamid; Imeh Ndiokho; Ethan Wen; Noelle C Garster; Marielle Scherrer-Crosbie; Sherry-Ann Brown
Journal:  Am Heart J Plus       Date:  2022-04-06

4.  Electrocardiogram-Artificial Intelligence and Immune-Mediated Necrotizing Myopathy: Predicting Left Ventricular Dysfunction and Clinical Outcomes.

Authors:  Christopher J Klein; Ilke Ozcan; Zachi I Attia; Michal Cohen-Shelly; Amir Lerman; Jose R Medina-Inojosa; Francisco Lopez-Jimenez; Paul A Friedman; Margherita Milone; Shahar Shelly
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2022-09-16

5.  Artificial Intelligence for Detection of Cardiovascular-Related Diseases from Wearable Devices: A Systematic Review and Meta-Analysis.

Authors:  Solam Lee; Yuseong Chu; Jiseung Ryu; Young Jun Park; Sejung Yang; Sang Baek Koh
Journal:  Yonsei Med J       Date:  2022-01       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.